Last reviewed · How we verify
Pipazethate (pipazetate)
Pipazethate (generic name: pipazetate) is a pipazetate drug. It is currently in unknown development.
Pipazetate is thought to work by interacting with a specific molecular target to produce its therapeutic effects.
Pipazethate is a small molecule drug that was briefly marketed as a cough suppressant. It binds to the sigma-1 receptor with an IC50 value of 190 nM and has local anesthetic action.
At a glance
| Generic name | pipazetate |
|---|---|
| Drug class | pipazetate |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your body's cells have locks on them, and pipazetate is a key that fits into one of those locks. When it binds to the lock, it can either unlock or block the normal functioning of the cell, depending on the specific target and the desired effect. This can help to either reduce or increase the activity of certain cellular processes.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pipazethate CI brief — competitive landscape report
- Pipazethate updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Pipazethate
What is Pipazethate?
How does Pipazethate work?
What is the generic name of Pipazethate?
What drug class is Pipazethate in?
What development phase is Pipazethate in?
Related
- Drug class: All pipazetate drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing